Jeffrey W. Sherman - Jun 8, 2021 Form 4 Insider Report for XERIS PHARMACEUTICALS INC (XERS)

Role
Director
Signature
/s/ Beth Hecht, as Attorney-in-Fact
Stock symbol
XERS
Transactions as of
Jun 8, 2021
Transactions value $
$0
Form type
4
Date filed
6/8/2021, 07:10 PM
Previous filing
May 18, 2021
Next filing
Jul 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XERS Stock Option (Right to Buy) Award $0 +11.2K $0.00 11.2K Jun 8, 2021 Common Stock 11.2K $3.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Such options will vest in full upon the earlier to occur of June 8, 2022 or the date of the Company's next annual meeting of stockholders.